Wednesday, April 6, 2016

Twist Bioscience Buys Genome Compiler

San Francisco-based Twist Bioscience Corporation, a developer of DNA synthesis and manufacturing technology, said this morning that it has acquired Genome Compiler, a developer of software for the genetic engineering, and molecular and synthetic biology market. Financial details of the acquisition were not announced. Genome Compiler is based in Israel. Twist Bioscience said the Genome Compiler research and development center in Tel Aviv will become Twist Bioscience's first international site. Genome Compiler was backed by Autodesk, LionBird VC and angel investors, and had raised $6M in funding; it was part of the NFX Guild incubator program.